Kaye Scholer Life Sciences Antitrust lawyers help clients navigate the complex web of antitrust rules that govern their conduct, prevent antitrust problems and, when they cannot be prevented, resolve them. Our experience and knowledge of the extensive regulatory structure within which life sciences companies must operate enables us to quickly master the particular situation presented and develop strategies to accomplish our clients' objectives, whether in the context of a proposed business deal or litigation. The Antitrust Group was recognized in Chambers USA: America's Leading Lawyers for Business for its "excellent degree of knowledge" and commended for its "raw brain power." MEHR
We regularly represent clients in litigation before federal and state courts throughout the United States and before the United States Department of Justice (DOJ) and Federal Trade Commission (FTC) in connection with investigations, merger clearances and other enforcement matters. We are well known to, and have good working relationships with, all of the current Federal Trade Commissioners (one of whom joined the Commission from our group), the Assistant Attorney General for Antitrust and many staff at both the DOJ and FTC, and members of our group have themselves held important leadership positions at these agencies and, in such capacities, have been responsible for cutting-edge litigation and investigations on behalf of the DOJ and FTC. We have substantial experience in clearing or challenging proposed business combinations with the DOJ and FTC. Our cases span the gamut of antitrust theories — including price-fixing, market allocation, monopolization, vertical restraints and Robinson-Patman Act price and promotional discrimination claims — often coupled with various state law antitrust, deceptive or unfair trade practices act claims.